nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—Lenalidomide—hematologic cancer	0.208	0.35	CbGbCtD
Tafluprost—PTGS2—Thalidomide—hematologic cancer	0.111	0.187	CbGbCtD
Tafluprost—PTGS2—Triamcinolone—hematologic cancer	0.077	0.129	CbGbCtD
Tafluprost—PTGS2—Betamethasone—hematologic cancer	0.0661	0.111	CbGbCtD
Tafluprost—PTGFR—ovarian follicle—hematologic cancer	0.0642	0.638	CbGeAlD
Tafluprost—PTGS2—Cisplatin—hematologic cancer	0.0476	0.08	CbGbCtD
Tafluprost—PTGS2—Etoposide—hematologic cancer	0.0467	0.0786	CbGbCtD
Tafluprost—PTGS2—Dexamethasone—hematologic cancer	0.0384	0.0646	CbGbCtD
Tafluprost—PTGS2—ovarian follicle—hematologic cancer	0.0176	0.175	CbGeAlD
Tafluprost—PTGFR—lung—hematologic cancer	0.0045	0.0447	CbGeAlD
Tafluprost—PTGFR—testis—hematologic cancer	0.00425	0.0422	CbGeAlD
Tafluprost—PTGFR—lymph node—hematologic cancer	0.00308	0.0306	CbGeAlD
Tafluprost—PTGS2—hematopoietic system—hematologic cancer	0.00213	0.0212	CbGeAlD
Tafluprost—Iloprost—PDE4B—hematologic cancer	0.00172	0.509	CrCbGaD
Tafluprost—Latanoprost—SLC22A1—hematologic cancer	0.00166	0.491	CrCbGaD
Tafluprost—PTGS2—blood—hematologic cancer	0.00141	0.014	CbGeAlD
Tafluprost—PTGS2—bone marrow—hematologic cancer	0.00136	0.0136	CbGeAlD
Tafluprost—PTGS2—lung—hematologic cancer	0.00124	0.0123	CbGeAlD
Tafluprost—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000858	0.209	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000858	0.209	CbGdCrCtD
Tafluprost—PTGS2—lymph node—hematologic cancer	0.000846	0.00841	CbGeAlD
Tafluprost—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000838	0.205	CbGdCrCtD
Tafluprost—Urinary tract infection—Nilotinib—hematologic cancer	0.000541	0.00319	CcSEcCtD
Tafluprost—Asthma—Lenalidomide—hematologic cancer	0.000541	0.00319	CcSEcCtD
Tafluprost—Urinary tract infection—Imatinib—hematologic cancer	0.000538	0.00317	CcSEcCtD
Tafluprost—Vision blurred—Anagrelide—hematologic cancer	0.000536	0.00317	CcSEcCtD
Tafluprost—Cough—Nelarabine—hematologic cancer	0.000533	0.00315	CcSEcCtD
Tafluprost—Eye disorder—Busulfan—hematologic cancer	0.000531	0.00313	CcSEcCtD
Tafluprost—Urinary tract infection—Cladribine—hematologic cancer	0.000528	0.00312	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000518	0.126	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000518	0.126	CbGdCrCtD
Tafluprost—Nasopharyngitis—Bortezomib—hematologic cancer	0.000515	0.00304	CcSEcCtD
Tafluprost—Headache—Ruxolitinib—hematologic cancer	0.00051	0.00301	CcSEcCtD
Tafluprost—Cataract—Triamcinolone—hematologic cancer	0.000506	0.00299	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000506	0.124	CbGdCrCtD
Tafluprost—Eye disorder—Bexarotene—hematologic cancer	0.000505	0.00298	CcSEcCtD
Tafluprost—Eye disorder—Dasatinib—hematologic cancer	0.000505	0.00298	CcSEcCtD
Tafluprost—Rhinitis—Nilotinib—hematologic cancer	0.0005	0.00295	CcSEcCtD
Tafluprost—Cough—Clofarabine—hematologic cancer	0.000499	0.00294	CcSEcCtD
Tafluprost—Cough—Daunorubicin—hematologic cancer	0.000499	0.00294	CcSEcCtD
Tafluprost—Rhinitis—Imatinib—hematologic cancer	0.000498	0.00294	CcSEcCtD
Tafluprost—Cough—Pentostatin—hematologic cancer	0.000496	0.00293	CcSEcCtD
Tafluprost—Cough—Anagrelide—hematologic cancer	0.000496	0.00293	CcSEcCtD
Tafluprost—Nervous system disorder—Nelarabine—hematologic cancer	0.000489	0.00288	CcSEcCtD
Tafluprost—Pruritus—Vorinostat—hematologic cancer	0.000487	0.00287	CcSEcCtD
Tafluprost—Urinary tract infection—Lenalidomide—hematologic cancer	0.000468	0.00277	CcSEcCtD
Tafluprost—Eye disorder—Nilotinib—hematologic cancer	0.000467	0.00275	CcSEcCtD
Tafluprost—Eye disorder—Imatinib—hematologic cancer	0.000464	0.00274	CcSEcCtD
Tafluprost—Cataract—Dexamethasone—hematologic cancer	0.000459	0.00271	CcSEcCtD
Tafluprost—Cataract—Betamethasone—hematologic cancer	0.000459	0.00271	CcSEcCtD
Tafluprost—Nervous system disorder—Clofarabine—hematologic cancer	0.000457	0.0027	CcSEcCtD
Tafluprost—Eye disorder—Cladribine—hematologic cancer	0.000456	0.00269	CcSEcCtD
Tafluprost—Nervous system disorder—Anagrelide—hematologic cancer	0.000455	0.00269	CcSEcCtD
Tafluprost—Nervous system disorder—Pentostatin—hematologic cancer	0.000455	0.00269	CcSEcCtD
Tafluprost—Dyspnoea—Nelarabine—hematologic cancer	0.000444	0.00262	CcSEcCtD
Tafluprost—Vision blurred—Dasatinib—hematologic cancer	0.000443	0.00262	CcSEcCtD
Tafluprost—Nasopharyngitis—Alitretinoin—hematologic cancer	0.000442	0.00261	CcSEcCtD
Tafluprost—Rhinitis—Lenalidomide—hematologic cancer	0.000434	0.00256	CcSEcCtD
Tafluprost—Cough—Busulfan—hematologic cancer	0.000432	0.00255	CcSEcCtD
Tafluprost—Urinary tract infection—Bortezomib—hematologic cancer	0.000431	0.00254	CcSEcCtD
Tafluprost—Headache—Vorinostat—hematologic cancer	0.000431	0.00254	CcSEcCtD
Tafluprost—Asthma—Alitretinoin—hematologic cancer	0.000427	0.00252	CcSEcCtD
Tafluprost—Cough—Procarbazine—hematologic cancer	0.000419	0.00247	CcSEcCtD
Tafluprost—Pruritus—Mechlorethamine—hematologic cancer	0.000418	0.00247	CcSEcCtD
Tafluprost—Dyspnoea—Clofarabine—hematologic cancer	0.000416	0.00245	CcSEcCtD
Tafluprost—Dyspnoea—Daunorubicin—hematologic cancer	0.000416	0.00245	CcSEcCtD
Tafluprost—Dyspnoea—Pentostatin—hematologic cancer	0.000414	0.00244	CcSEcCtD
Tafluprost—Dyspnoea—Anagrelide—hematologic cancer	0.000414	0.00244	CcSEcCtD
Tafluprost—Cough—Dasatinib—hematologic cancer	0.00041	0.00242	CcSEcCtD
Tafluprost—Cough—Bexarotene—hematologic cancer	0.00041	0.00242	CcSEcCtD
Tafluprost—Vision blurred—Nilotinib—hematologic cancer	0.00041	0.00242	CcSEcCtD
Tafluprost—Cough—Fludarabine—hematologic cancer	0.000409	0.00242	CcSEcCtD
Tafluprost—Vision blurred—Imatinib—hematologic cancer	0.000407	0.0024	CcSEcCtD
Tafluprost—Eye disorder—Lenalidomide—hematologic cancer	0.000404	0.00239	CcSEcCtD
Tafluprost—Dry eye—Betamethasone—hematologic cancer	0.000404	0.00238	CcSEcCtD
Tafluprost—Dry eye—Dexamethasone—hematologic cancer	0.000404	0.00238	CcSEcCtD
Tafluprost—Cataract—Prednisone—hematologic cancer	0.0004	0.00236	CcSEcCtD
Tafluprost—Nervous system disorder—Busulfan—hematologic cancer	0.000396	0.00234	CcSEcCtD
Tafluprost—Dyspnoea—Teniposide—hematologic cancer	0.000388	0.00229	CcSEcCtD
Tafluprost—Cough—Nilotinib—hematologic cancer	0.000379	0.00224	CcSEcCtD
Tafluprost—Cough—Imatinib—hematologic cancer	0.000377	0.00223	CcSEcCtD
Tafluprost—Nervous system disorder—Bexarotene—hematologic cancer	0.000376	0.00222	CcSEcCtD
Tafluprost—Nervous system disorder—Dasatinib—hematologic cancer	0.000376	0.00222	CcSEcCtD
Tafluprost—Nasopharyngitis—Cisplatin—hematologic cancer	0.000376	0.00222	CcSEcCtD
Tafluprost—Nervous system disorder—Fludarabine—hematologic cancer	0.000375	0.00222	CcSEcCtD
Tafluprost—Urinary tract infection—Carmustine—hematologic cancer	0.000373	0.0022	CcSEcCtD
Tafluprost—Eye disorder—Bortezomib—hematologic cancer	0.000372	0.0022	CcSEcCtD
Tafluprost—Cough—Cladribine—hematologic cancer	0.000371	0.00219	CcSEcCtD
Tafluprost—Urinary tract infection—Alitretinoin—hematologic cancer	0.00037	0.00218	CcSEcCtD
Tafluprost—Rhinitis—Thalidomide—hematologic cancer	0.00036	0.00213	CcSEcCtD
Tafluprost—Dyspnoea—Busulfan—hematologic cancer	0.00036	0.00212	CcSEcCtD
Tafluprost—Vision blurred—Lenalidomide—hematologic cancer	0.000355	0.0021	CcSEcCtD
Tafluprost—Eye pain—Dexamethasone—hematologic cancer	0.000351	0.00207	CcSEcCtD
Tafluprost—Eye pain—Betamethasone—hematologic cancer	0.000351	0.00207	CcSEcCtD
Tafluprost—Nervous system disorder—Nilotinib—hematologic cancer	0.000348	0.00205	CcSEcCtD
Tafluprost—Urinary tract infection—Mitoxantrone—hematologic cancer	0.000347	0.00205	CcSEcCtD
Tafluprost—Eye disorder—Thiotepa—hematologic cancer	0.000347	0.00205	CcSEcCtD
Tafluprost—Nervous system disorder—Imatinib—hematologic cancer	0.000346	0.00204	CcSEcCtD
Tafluprost—Pruritus—Methoxsalen—hematologic cancer	0.000344	0.00203	CcSEcCtD
Tafluprost—Dyspnoea—Bexarotene—hematologic cancer	0.000342	0.00202	CcSEcCtD
Tafluprost—Dyspnoea—Dasatinib—hematologic cancer	0.000342	0.00202	CcSEcCtD
Tafluprost—Dyspnoea—Fludarabine—hematologic cancer	0.000341	0.00201	CcSEcCtD
Tafluprost—Nervous system disorder—Cladribine—hematologic cancer	0.00034	0.00201	CcSEcCtD
Tafluprost—Cough—Melphalan—hematologic cancer	0.000338	0.002	CcSEcCtD
Tafluprost—Eye disorder—Thalidomide—hematologic cancer	0.000336	0.00198	CcSEcCtD
Tafluprost—Pruritus—Clofarabine—hematologic cancer	0.00033	0.00195	CcSEcCtD
Tafluprost—Pruritus—Daunorubicin—hematologic cancer	0.00033	0.00195	CcSEcCtD
Tafluprost—Cough—Lenalidomide—hematologic cancer	0.000329	0.00194	CcSEcCtD
Tafluprost—Pruritus—Pentostatin—hematologic cancer	0.000329	0.00194	CcSEcCtD
Tafluprost—Pruritus—Anagrelide—hematologic cancer	0.000329	0.00194	CcSEcCtD
Tafluprost—Vision blurred—Bortezomib—hematologic cancer	0.000327	0.00193	CcSEcCtD
Tafluprost—Lacrimation increased—Epirubicin—hematologic cancer	0.000323	0.00191	CcSEcCtD
Tafluprost—Eye disorder—Carmustine—hematologic cancer	0.000322	0.0019	CcSEcCtD
Tafluprost—Rhinitis—Mitoxantrone—hematologic cancer	0.000321	0.0019	CcSEcCtD
Tafluprost—Rhinitis—Irinotecan—hematologic cancer	0.000321	0.0019	CcSEcCtD
Tafluprost—Eye disorder—Alitretinoin—hematologic cancer	0.000319	0.00188	CcSEcCtD
Tafluprost—Dyspnoea—Nilotinib—hematologic cancer	0.000316	0.00187	CcSEcCtD
Tafluprost—Eye disorder—Ifosfamide—hematologic cancer	0.000316	0.00186	CcSEcCtD
Tafluprost—Dyspnoea—Imatinib—hematologic cancer	0.000314	0.00186	CcSEcCtD
Tafluprost—Rhinitis—Gemcitabine—hematologic cancer	0.000313	0.00185	CcSEcCtD
Tafluprost—Headache—Nelarabine—hematologic cancer	0.000312	0.00184	CcSEcCtD
Tafluprost—Dyspnoea—Cladribine—hematologic cancer	0.000309	0.00182	CcSEcCtD
Tafluprost—Pruritus—Teniposide—hematologic cancer	0.000308	0.00182	CcSEcCtD
Tafluprost—Headache—Methoxsalen—hematologic cancer	0.000305	0.0018	CcSEcCtD
Tafluprost—Vision blurred—Thiotepa—hematologic cancer	0.000305	0.0018	CcSEcCtD
Tafluprost—Cough—Bortezomib—hematologic cancer	0.000302	0.00179	CcSEcCtD
Tafluprost—Asthma—Triamcinolone—hematologic cancer	0.000302	0.00178	CcSEcCtD
Tafluprost—Nervous system disorder—Lenalidomide—hematologic cancer	0.000301	0.00178	CcSEcCtD
Tafluprost—Cough—Bleomycin—hematologic cancer	0.0003	0.00177	CcSEcCtD
Tafluprost—Lacrimation increased—Doxorubicin—hematologic cancer	0.000299	0.00176	CcSEcCtD
Tafluprost—Nervous system disorder—Hydroxyurea—hematologic cancer	0.000297	0.00175	CcSEcCtD
Tafluprost—Cough—Vinorelbine—hematologic cancer	0.000295	0.00174	CcSEcCtD
Tafluprost—Vision blurred—Thalidomide—hematologic cancer	0.000295	0.00174	CcSEcCtD
Tafluprost—Headache—Clofarabine—hematologic cancer	0.000292	0.00172	CcSEcCtD
Tafluprost—Headache—Daunorubicin—hematologic cancer	0.000292	0.00172	CcSEcCtD
Tafluprost—Headache—Pentostatin—hematologic cancer	0.000291	0.00172	CcSEcCtD
Tafluprost—Headache—Anagrelide—hematologic cancer	0.000291	0.00172	CcSEcCtD
Tafluprost—Pruritus—Busulfan—hematologic cancer	0.000286	0.00169	CcSEcCtD
Tafluprost—Vision blurred—Carmustine—hematologic cancer	0.000283	0.00167	CcSEcCtD
Tafluprost—Cough—Thiotepa—hematologic cancer	0.000282	0.00166	CcSEcCtD
Tafluprost—Dyspnoea—Melphalan—hematologic cancer	0.000282	0.00166	CcSEcCtD
Tafluprost—Headache—Idarubicin—hematologic cancer	0.000281	0.00166	CcSEcCtD
Tafluprost—Vision blurred—Alitretinoin—hematologic cancer	0.00028	0.00165	CcSEcCtD
Tafluprost—Nervous system disorder—Bortezomib—hematologic cancer	0.000277	0.00164	CcSEcCtD
Tafluprost—Pruritus—Procarbazine—hematologic cancer	0.000277	0.00164	CcSEcCtD
Tafluprost—Vision blurred—Ifosfamide—hematologic cancer	0.000277	0.00164	CcSEcCtD
Tafluprost—Dry eye—Epirubicin—hematologic cancer	0.000275	0.00162	CcSEcCtD
Tafluprost—Dyspnoea—Lenalidomide—hematologic cancer	0.000274	0.00162	CcSEcCtD
Tafluprost—Headache—Teniposide—hematologic cancer	0.000273	0.00161	CcSEcCtD
Tafluprost—Cough—Thalidomide—hematologic cancer	0.000273	0.00161	CcSEcCtD
Tafluprost—Eye disorder—Cisplatin—hematologic cancer	0.000272	0.00161	CcSEcCtD
Tafluprost—Pruritus—Bexarotene—hematologic cancer	0.000272	0.0016	CcSEcCtD
Tafluprost—Pruritus—Dasatinib—hematologic cancer	0.000272	0.0016	CcSEcCtD
Tafluprost—Pruritus—Fludarabine—hematologic cancer	0.000271	0.0016	CcSEcCtD
Tafluprost—Nervous system disorder—Vinorelbine—hematologic cancer	0.000271	0.0016	CcSEcCtD
Tafluprost—Dyspnoea—Hydroxyurea—hematologic cancer	0.00027	0.0016	CcSEcCtD
Tafluprost—Vision blurred—Mitoxantrone—hematologic cancer	0.000263	0.00155	CcSEcCtD
Tafluprost—Cough—Alitretinoin—hematologic cancer	0.00026	0.00153	CcSEcCtD
Tafluprost—Nervous system disorder—Thiotepa—hematologic cancer	0.000259	0.00153	CcSEcCtD
Tafluprost—Pruritus—Chlorambucil—hematologic cancer	0.000257	0.00151	CcSEcCtD
Tafluprost—Cough—Ifosfamide—hematologic cancer	0.000256	0.00151	CcSEcCtD
Tafluprost—Dry eye—Doxorubicin—hematologic cancer	0.000254	0.0015	CcSEcCtD
Tafluprost—Headache—Busulfan—hematologic cancer	0.000253	0.00149	CcSEcCtD
Tafluprost—Dyspnoea—Bortezomib—hematologic cancer	0.000252	0.00149	CcSEcCtD
Tafluprost—Pruritus—Nilotinib—hematologic cancer	0.000251	0.00148	CcSEcCtD
Tafluprost—Dyspnoea—Bleomycin—hematologic cancer	0.00025	0.00148	CcSEcCtD
Tafluprost—Nervous system disorder—Thalidomide—hematologic cancer	0.00025	0.00148	CcSEcCtD
Tafluprost—Pruritus—Imatinib—hematologic cancer	0.00025	0.00147	CcSEcCtD
Tafluprost—Eye disorder—Etoposide—hematologic cancer	0.000249	0.00147	CcSEcCtD
Tafluprost—Dyspnoea—Vinorelbine—hematologic cancer	0.000246	0.00145	CcSEcCtD
Tafluprost—Headache—Procarbazine—hematologic cancer	0.000245	0.00145	CcSEcCtD
Tafluprost—Pruritus—Cladribine—hematologic cancer	0.000245	0.00145	CcSEcCtD
Tafluprost—Cough—Irinotecan—hematologic cancer	0.000244	0.00144	CcSEcCtD
Tafluprost—Cough—Mitoxantrone—hematologic cancer	0.000244	0.00144	CcSEcCtD
Tafluprost—Rhinitis—Triamcinolone—hematologic cancer	0.000242	0.00143	CcSEcCtD
Tafluprost—Headache—Bexarotene—hematologic cancer	0.00024	0.00142	CcSEcCtD
Tafluprost—Headache—Dasatinib—hematologic cancer	0.00024	0.00142	CcSEcCtD
Tafluprost—Headache—Fludarabine—hematologic cancer	0.00024	0.00142	CcSEcCtD
Tafluprost—Eye pain—Epirubicin—hematologic cancer	0.000239	0.00141	CcSEcCtD
Tafluprost—Vision blurred—Cisplatin—hematologic cancer	0.000239	0.00141	CcSEcCtD
Tafluprost—Nervous system disorder—Alitretinoin—hematologic cancer	0.000238	0.00141	CcSEcCtD
Tafluprost—Cough—Gemcitabine—hematologic cancer	0.000237	0.0014	CcSEcCtD
Tafluprost—Nervous system disorder—Ifosfamide—hematologic cancer	0.000235	0.00139	CcSEcCtD
Tafluprost—Nervous system disorder—Vincristine—hematologic cancer	0.000229	0.00135	CcSEcCtD
Tafluprost—Dyspnoea—Thalidomide—hematologic cancer	0.000227	0.00134	CcSEcCtD
Tafluprost—Pruritus—Melphalan—hematologic cancer	0.000224	0.00132	CcSEcCtD
Tafluprost—Nervous system disorder—Irinotecan—hematologic cancer	0.000223	0.00132	CcSEcCtD
Tafluprost—Headache—Nilotinib—hematologic cancer	0.000222	0.00131	CcSEcCtD
Tafluprost—Eye pain—Doxorubicin—hematologic cancer	0.000221	0.00131	CcSEcCtD
Tafluprost—Headache—Imatinib—hematologic cancer	0.000221	0.0013	CcSEcCtD
Tafluprost—Dyspnoea—Carmustine—hematologic cancer	0.000218	0.00129	CcSEcCtD
Tafluprost—Nervous system disorder—Gemcitabine—hematologic cancer	0.000218	0.00128	CcSEcCtD
Tafluprost—Pruritus—Lenalidomide—hematologic cancer	0.000217	0.00128	CcSEcCtD
Tafluprost—Headache—Cladribine—hematologic cancer	0.000217	0.00128	CcSEcCtD
Tafluprost—Dyspnoea—Alitretinoin—hematologic cancer	0.000216	0.00128	CcSEcCtD
Tafluprost—Vision blurred—Prednisolone—hematologic cancer	0.000216	0.00127	CcSEcCtD
Tafluprost—Dyspnoea—Ifosfamide—hematologic cancer	0.000214	0.00126	CcSEcCtD
Tafluprost—Headache—Vinblastine—hematologic cancer	0.000208	0.00123	CcSEcCtD
Tafluprost—Eye disorder—Betamethasone—hematologic cancer	0.000205	0.00121	CcSEcCtD
Tafluprost—Eye disorder—Dexamethasone—hematologic cancer	0.000205	0.00121	CcSEcCtD
Tafluprost—Dyspnoea—Mitoxantrone—hematologic cancer	0.000203	0.0012	CcSEcCtD
Tafluprost—Dyspnoea—Irinotecan—hematologic cancer	0.000203	0.0012	CcSEcCtD
Tafluprost—Nervous system disorder—Cisplatin—hematologic cancer	0.000203	0.0012	CcSEcCtD
Tafluprost—Cough—Etoposide—hematologic cancer	0.000203	0.0012	CcSEcCtD
Tafluprost—Pruritus—Bortezomib—hematologic cancer	0.0002	0.00118	CcSEcCtD
Tafluprost—Asthma—Methotrexate—hematologic cancer	0.0002	0.00118	CcSEcCtD
Tafluprost—Pruritus—Bleomycin—hematologic cancer	0.000199	0.00117	CcSEcCtD
Tafluprost—Dyspnoea—Gemcitabine—hematologic cancer	0.000198	0.00117	CcSEcCtD
Tafluprost—Pruritus—Vinorelbine—hematologic cancer	0.000195	0.00115	CcSEcCtD
Tafluprost—Nasopharyngitis—Epirubicin—hematologic cancer	0.000193	0.00114	CcSEcCtD
Tafluprost—Headache—Lenalidomide—hematologic cancer	0.000193	0.00114	CcSEcCtD
Tafluprost—Headache—Hydroxyurea—hematologic cancer	0.00019	0.00112	CcSEcCtD
Tafluprost—Asthma—Epirubicin—hematologic cancer	0.000187	0.0011	CcSEcCtD
Tafluprost—Pruritus—Thiotepa—hematologic cancer	0.000187	0.0011	CcSEcCtD
Tafluprost—Dyspnoea—Cisplatin—hematologic cancer	0.000184	0.00109	CcSEcCtD
Tafluprost—Cough—Triamcinolone—hematologic cancer	0.000184	0.00108	CcSEcCtD
Tafluprost—Pruritus—Thalidomide—hematologic cancer	0.00018	0.00107	CcSEcCtD
Tafluprost—Nasopharyngitis—Doxorubicin—hematologic cancer	0.000179	0.00106	CcSEcCtD
Tafluprost—Eye disorder—Prednisone—hematologic cancer	0.000179	0.00105	CcSEcCtD
Tafluprost—Headache—Bortezomib—hematologic cancer	0.000177	0.00105	CcSEcCtD
Tafluprost—Headache—Vinorelbine—hematologic cancer	0.000173	0.00102	CcSEcCtD
Tafluprost—Asthma—Doxorubicin—hematologic cancer	0.000173	0.00102	CcSEcCtD
Tafluprost—Pruritus—Alitretinoin—hematologic cancer	0.000172	0.00101	CcSEcCtD
Tafluprost—Pruritus—Ifosfamide—hematologic cancer	0.00017	0.001	CcSEcCtD
Tafluprost—Dyspnoea—Etoposide—hematologic cancer	0.000169	0.000997	CcSEcCtD
Tafluprost—Headache—Thiotepa—hematologic cancer	0.000165	0.000975	CcSEcCtD
Tafluprost—Urinary tract infection—Epirubicin—hematologic cancer	0.000162	0.000955	CcSEcCtD
Tafluprost—Headache—Thalidomide—hematologic cancer	0.00016	0.000943	CcSEcCtD
Tafluprost—Pruritus—Gemcitabine—hematologic cancer	0.000157	0.000927	CcSEcCtD
Tafluprost—Vision blurred—Prednisone—hematologic cancer	0.000157	0.000926	CcSEcCtD
Tafluprost—Headache—Carmustine—hematologic cancer	0.000153	0.000906	CcSEcCtD
Tafluprost—Dyspnoea—Triamcinolone—hematologic cancer	0.000153	0.000904	CcSEcCtD
Tafluprost—Nervous system disorder—Dexamethasone—hematologic cancer	0.000153	0.000903	CcSEcCtD
Tafluprost—Nervous system disorder—Betamethasone—hematologic cancer	0.000153	0.000903	CcSEcCtD
Tafluprost—Headache—Alitretinoin—hematologic cancer	0.000152	0.000898	CcSEcCtD
Tafluprost—Rhinitis—Epirubicin—hematologic cancer	0.00015	0.000885	CcSEcCtD
Tafluprost—Urinary tract infection—Doxorubicin—hematologic cancer	0.00015	0.000884	CcSEcCtD
Tafluprost—Eye disorder—Methotrexate—hematologic cancer	0.000149	0.000881	CcSEcCtD
Tafluprost—Headache—Vincristine—hematologic cancer	0.000147	0.000865	CcSEcCtD
Tafluprost—Headache—Irinotecan—hematologic cancer	0.000143	0.000842	CcSEcCtD
Tafluprost—Headache—Mitoxantrone—hematologic cancer	0.000143	0.000842	CcSEcCtD
Tafluprost—Eye disorder—Epirubicin—hematologic cancer	0.00014	0.000825	CcSEcCtD
Tafluprost—Headache—Gemcitabine—hematologic cancer	0.000139	0.000821	CcSEcCtD
Tafluprost—Rhinitis—Doxorubicin—hematologic cancer	0.000139	0.000819	CcSEcCtD
Tafluprost—Pruritus—Etoposide—hematologic cancer	0.000134	0.000791	CcSEcCtD
Tafluprost—Nervous system disorder—Prednisone—hematologic cancer	0.000133	0.000786	CcSEcCtD
Tafluprost—Vision blurred—Methotrexate—hematologic cancer	0.000131	0.000774	CcSEcCtD
Tafluprost—Eye disorder—Doxorubicin—hematologic cancer	0.000129	0.000763	CcSEcCtD
Tafluprost—Vision blurred—Epirubicin—hematologic cancer	0.000123	0.000724	CcSEcCtD
Tafluprost—Pruritus—Triamcinolone—hematologic cancer	0.000122	0.000718	CcSEcCtD
Tafluprost—Cough—Methotrexate—hematologic cancer	0.000121	0.000716	CcSEcCtD
Tafluprost—Headache—Etoposide—hematologic cancer	0.000119	0.000701	CcSEcCtD
Tafluprost—Headache—Prednisolone—hematologic cancer	0.000117	0.000691	CcSEcCtD
Tafluprost—Cough—Epirubicin—hematologic cancer	0.000114	0.00067	CcSEcCtD
Tafluprost—Vision blurred—Doxorubicin—hematologic cancer	0.000113	0.00067	CcSEcCtD
Tafluprost—Nervous system disorder—Methotrexate—hematologic cancer	0.000111	0.000657	CcSEcCtD
Tafluprost—Pruritus—Betamethasone—hematologic cancer	0.00011	0.000651	CcSEcCtD
Tafluprost—Pruritus—Dexamethasone—hematologic cancer	0.00011	0.000651	CcSEcCtD
Tafluprost—Headache—Triamcinolone—hematologic cancer	0.000108	0.000636	CcSEcCtD
Tafluprost—Cough—Doxorubicin—hematologic cancer	0.000105	0.00062	CcSEcCtD
Tafluprost—Nervous system disorder—Epirubicin—hematologic cancer	0.000104	0.000615	CcSEcCtD
Tafluprost—Dyspnoea—Methotrexate—hematologic cancer	0.000101	0.000597	CcSEcCtD
Tafluprost—Headache—Dexamethasone—hematologic cancer	9.77e-05	0.000577	CcSEcCtD
Tafluprost—Headache—Betamethasone—hematologic cancer	9.77e-05	0.000577	CcSEcCtD
Tafluprost—Nervous system disorder—Doxorubicin—hematologic cancer	9.64e-05	0.000569	CcSEcCtD
Tafluprost—Pruritus—Prednisone—hematologic cancer	9.61e-05	0.000567	CcSEcCtD
Tafluprost—Dyspnoea—Epirubicin—hematologic cancer	9.47e-05	0.000559	CcSEcCtD
Tafluprost—Dyspnoea—Doxorubicin—hematologic cancer	8.76e-05	0.000517	CcSEcCtD
Tafluprost—Headache—Prednisone—hematologic cancer	8.51e-05	0.000502	CcSEcCtD
Tafluprost—Pruritus—Methotrexate—hematologic cancer	8.03e-05	0.000474	CcSEcCtD
Tafluprost—Pruritus—Epirubicin—hematologic cancer	7.51e-05	0.000444	CcSEcCtD
Tafluprost—Headache—Methotrexate—hematologic cancer	7.11e-05	0.00042	CcSEcCtD
Tafluprost—Pruritus—Doxorubicin—hematologic cancer	6.95e-05	0.00041	CcSEcCtD
Tafluprost—Headache—Epirubicin—hematologic cancer	6.65e-05	0.000393	CcSEcCtD
Tafluprost—Headache—Doxorubicin—hematologic cancer	6.16e-05	0.000363	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—IL6R—hematologic cancer	4.42e-05	0.000346	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3R1—hematologic cancer	4.35e-05	0.000341	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LEF1—hematologic cancer	4.28e-05	0.000335	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTAP—hematologic cancer	4.25e-05	0.000333	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	4.25e-05	0.000333	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—JAK2—hematologic cancer	4.23e-05	0.000332	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAP2K1—hematologic cancer	4.21e-05	0.00033	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HMMR—hematologic cancer	4.2e-05	0.000329	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GRB2—hematologic cancer	4.19e-05	0.000329	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CD—hematologic cancer	4.19e-05	0.000328	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFA—hematologic cancer	4.18e-05	0.000328	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	4.16e-05	0.000326	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KITLG—hematologic cancer	4.12e-05	0.000323	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	4.05e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	4.04e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT5A—hematologic cancer	4.03e-05	0.000316	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CB—hematologic cancer	4.02e-05	0.000315	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN2B—hematologic cancer	3.99e-05	0.000313	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3R1—hematologic cancer	3.95e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ELL—hematologic cancer	3.95e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	3.92e-05	0.000307	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.92e-05	0.000307	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.91e-05	0.000306	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CD86—hematologic cancer	3.86e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ACP5—hematologic cancer	3.85e-05	0.000301	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—JAK2—hematologic cancer	3.84e-05	0.000301	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.82e-05	0.0003	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HES1—hematologic cancer	3.81e-05	0.000299	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NCOR2—hematologic cancer	3.8e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NCOR1—hematologic cancer	3.79e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FHL2—hematologic cancer	3.79e-05	0.000297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CSF2—hematologic cancer	3.75e-05	0.000294	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF1—hematologic cancer	3.75e-05	0.000294	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.73e-05	0.000292	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AGRN—hematologic cancer	3.71e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FOXO1—hematologic cancer	3.69e-05	0.000289	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—hematologic cancer	3.69e-05	0.000289	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFRB—hematologic cancer	3.69e-05	0.000289	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CB—hematologic cancer	3.65e-05	0.000286	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFRA—hematologic cancer	3.63e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.63e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JAK1—hematologic cancer	3.62e-05	0.000283	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCG—hematologic cancer	3.62e-05	0.000283	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IDH1—hematologic cancer	3.62e-05	0.000283	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	3.59e-05	0.000281	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GSTO1—hematologic cancer	3.58e-05	0.00028	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.53e-05	0.000277	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMMR—hematologic cancer	3.52e-05	0.000276	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—IDH2—hematologic cancer	3.52e-05	0.000276	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AGO2—hematologic cancer	3.5e-05	0.000274	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HDAC9—hematologic cancer	3.46e-05	0.000271	CbGpPWpGaD
Tafluprost—PTGS2—Disease—H3F3B—hematologic cancer	3.43e-05	0.000269	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2RA—hematologic cancer	3.38e-05	0.000265	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—hematologic cancer	3.35e-05	0.000263	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.34e-05	0.000262	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TERT—hematologic cancer	3.34e-05	0.000262	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.32e-05	0.00026	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ARNTL—hematologic cancer	3.31e-05	0.000259	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NPM1—hematologic cancer	3.3e-05	0.000258	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFB—hematologic cancer	3.26e-05	0.000255	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.25e-05	0.000255	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.24e-05	0.000254	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACP5—hematologic cancer	3.22e-05	0.000252	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CA9—hematologic cancer	3.22e-05	0.000252	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TSC2—hematologic cancer	3.19e-05	0.00025	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOR2—hematologic cancer	3.18e-05	0.000249	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF19—hematologic cancer	3.16e-05	0.000248	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS14—hematologic cancer	3.13e-05	0.000246	CbGpPWpGaD
Tafluprost—PTGS2—Disease—DKK1—hematologic cancer	3.11e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT5B—hematologic cancer	3.09e-05	0.000242	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NUP98—hematologic cancer	3.09e-05	0.000242	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGFR3—hematologic cancer	3.06e-05	0.00024	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK14—hematologic cancer	3.03e-05	0.000238	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—IDH1—hematologic cancer	3.03e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	3.03e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CST3—hematologic cancer	3.02e-05	0.000236	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	3e-05	0.000235	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADCY7—hematologic cancer	3e-05	0.000235	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTO1—hematologic cancer	2.99e-05	0.000235	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCC3—hematologic cancer	2.99e-05	0.000235	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TXN—hematologic cancer	2.99e-05	0.000235	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ESR1—hematologic cancer	2.98e-05	0.000233	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NUP214—hematologic cancer	2.97e-05	0.000233	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FN1—hematologic cancer	2.94e-05	0.00023	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SPHK1—hematologic cancer	2.93e-05	0.00023	CbGpPWpGaD
Tafluprost—PTGS2—Disease—XIAP—hematologic cancer	2.91e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTR—hematologic cancer	2.91e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKBIA—hematologic cancer	2.91e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BAD—hematologic cancer	2.91e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH1—hematologic cancer	2.88e-05	0.000225	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ENO2—hematologic cancer	2.86e-05	0.000224	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SMARCA4—hematologic cancer	2.84e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CD80—hematologic cancer	2.82e-05	0.000221	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.81e-05	0.000221	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CG—hematologic cancer	2.81e-05	0.00022	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KIT—hematologic cancer	2.81e-05	0.00022	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NRAS—hematologic cancer	2.81e-05	0.00022	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTPN11—hematologic cancer	2.76e-05	0.000217	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.76e-05	0.000216	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CRABP1—hematologic cancer	2.74e-05	0.000215	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.74e-05	0.000215	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SDC1—hematologic cancer	2.71e-05	0.000212	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAPK3—hematologic cancer	2.69e-05	0.000211	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CREB1—hematologic cancer	2.68e-05	0.00021	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALOX5—hematologic cancer	2.67e-05	0.000209	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.67e-05	0.000209	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BRAF—hematologic cancer	2.64e-05	0.000207	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LCK—hematologic cancer	2.62e-05	0.000206	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL2—hematologic cancer	2.62e-05	0.000205	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6R—hematologic cancer	2.61e-05	0.000205	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CREBBP—hematologic cancer	2.61e-05	0.000204	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NUP98—hematologic cancer	2.58e-05	0.000202	CbGpPWpGaD
Tafluprost—PTGS2—Disease—H3F3A—hematologic cancer	2.57e-05	0.000202	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADCY7—hematologic cancer	2.51e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOA3—hematologic cancer	2.51e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKCZ—hematologic cancer	2.5e-05	0.000196	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NUP214—hematologic cancer	2.49e-05	0.000195	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAP2K1—hematologic cancer	2.49e-05	0.000195	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CD—hematologic cancer	2.47e-05	0.000194	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.47e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CALR—hematologic cancer	2.46e-05	0.000192	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—hematologic cancer	2.45e-05	0.000192	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTR—hematologic cancer	2.44e-05	0.000191	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCG2—hematologic cancer	2.44e-05	0.000191	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—hematologic cancer	2.42e-05	0.00019	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PARP1—hematologic cancer	2.41e-05	0.000189	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENO2—hematologic cancer	2.39e-05	0.000188	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FBXW7—hematologic cancer	2.38e-05	0.000186	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF2—hematologic cancer	2.37e-05	0.000186	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3R1—hematologic cancer	2.34e-05	0.000183	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HDAC2—hematologic cancer	2.33e-05	0.000183	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CXCR4—hematologic cancer	2.33e-05	0.000183	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTT1—hematologic cancer	2.32e-05	0.000182	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD44—hematologic cancer	2.3e-05	0.00018	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.29e-05	0.000179	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CBL—hematologic cancer	2.27e-05	0.000178	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JAK2—hematologic cancer	2.27e-05	0.000178	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SDC1—hematologic cancer	2.27e-05	0.000178	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.25e-05	0.000177	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—hematologic cancer	2.22e-05	0.000174	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MDM2—hematologic cancer	2.22e-05	0.000174	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.17e-05	0.00017	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HSP90AA1—hematologic cancer	2.17e-05	0.00017	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MTOR—hematologic cancer	2.16e-05	0.000169	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CB—hematologic cancer	2.16e-05	0.000169	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.14e-05	0.000168	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT1—hematologic cancer	2.09e-05	0.000164	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HRAS—hematologic cancer	2.06e-05	0.000161	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.05e-05	0.00016	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1B—hematologic cancer	2.02e-05	0.000159	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—hematologic cancer	2e-05	0.000157	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—hematologic cancer	1.98e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—hematologic cancer	1.98e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—hematologic cancer	1.97e-05	0.000154	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GRB2—hematologic cancer	1.95e-05	0.000153	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFA—hematologic cancer	1.95e-05	0.000153	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCND1—hematologic cancer	1.93e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NQO1—hematologic cancer	1.93e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CD44—hematologic cancer	1.93e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUN—hematologic cancer	1.93e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KITLG—hematologic cancer	1.92e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.89e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT5A—hematologic cancer	1.88e-05	0.000147	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1A—hematologic cancer	1.87e-05	0.000146	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTEN—hematologic cancer	1.86e-05	0.000146	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN2B—hematologic cancer	1.86e-05	0.000146	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYCS—hematologic cancer	1.83e-05	0.000143	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK8—hematologic cancer	1.82e-05	0.000143	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—hematologic cancer	1.82e-05	0.000142	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.81e-05	0.000142	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD86—hematologic cancer	1.8e-05	0.000141	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EP300—hematologic cancer	1.78e-05	0.000139	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HES1—hematologic cancer	1.78e-05	0.000139	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NCOR1—hematologic cancer	1.77e-05	0.000138	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF1—hematologic cancer	1.75e-05	0.000137	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SRC—hematologic cancer	1.73e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FOXO1—hematologic cancer	1.72e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFRB—hematologic cancer	1.72e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFRA—hematologic cancer	1.69e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JAK1—hematologic cancer	1.69e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKCG—hematologic cancer	1.69e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—hematologic cancer	1.68e-05	0.000132	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—hematologic cancer	1.67e-05	0.000131	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NRAS—hematologic cancer	1.66e-05	0.00013	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.63e-05	0.000128	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTP1—hematologic cancer	1.61e-05	0.000126	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK3—hematologic cancer	1.59e-05	0.000125	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—hematologic cancer	1.56e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.56e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TERT—hematologic cancer	1.56e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HLA-A—hematologic cancer	1.56e-05	0.000122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—hematologic cancer	1.55e-05	0.000121	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—hematologic cancer	1.54e-05	0.000121	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCB1—hematologic cancer	1.52e-05	0.000119	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFB—hematologic cancer	1.52e-05	0.000119	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TSC2—hematologic cancer	1.48e-05	0.000116	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOR1—hematologic cancer	1.48e-05	0.000116	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM1—hematologic cancer	1.48e-05	0.000116	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—hematologic cancer	1.43e-05	0.000112	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGFR3—hematologic cancer	1.43e-05	0.000112	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BAD—hematologic cancer	1.35e-05	0.000106	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOTCH1—hematologic cancer	1.34e-05	0.000105	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—hematologic cancer	1.31e-05	0.000103	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD80—hematologic cancer	1.31e-05	0.000103	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KIT—hematologic cancer	1.31e-05	0.000103	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—hematologic cancer	1.31e-05	0.000102	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PTPN11—hematologic cancer	1.29e-05	0.000101	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—hematologic cancer	1.27e-05	9.96e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CREB1—hematologic cancer	1.25e-05	9.78e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BRAF—hematologic cancer	1.23e-05	9.66e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6R—hematologic cancer	1.22e-05	9.54e-05	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRAS—hematologic cancer	1.22e-05	9.53e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CREBBP—hematologic cancer	1.22e-05	9.52e-05	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—hematologic cancer	1.16e-05	9.12e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAP2K1—hematologic cancer	1.16e-05	9.09e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CD—hematologic cancer	1.15e-05	9.03e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.15e-05	9.02e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF2—hematologic cancer	1.1e-05	8.65e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CG—hematologic cancer	1.1e-05	8.6e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3R1—hematologic cancer	1.09e-05	8.53e-05	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—hematologic cancer	1.07e-05	8.41e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—JAK2—hematologic cancer	1.06e-05	8.29e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MDM2—hematologic cancer	1.03e-05	8.09e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CREBBP—hematologic cancer	1.02e-05	7.98e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CB—hematologic cancer	1e-05	7.87e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTOR—hematologic cancer	1e-05	7.87e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—hematologic cancer	1e-05	7.86e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CD—hematologic cancer	9.65e-06	7.56e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—hematologic cancer	9.53e-06	7.47e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1B—hematologic cancer	9.43e-06	7.39e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3R1—hematologic cancer	9.11e-06	7.14e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1A—hematologic cancer	8.7e-06	6.82e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PTEN—hematologic cancer	8.68e-06	6.8e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CB—hematologic cancer	8.41e-06	6.59e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EP300—hematologic cancer	8.28e-06	6.49e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SRC—hematologic cancer	8.05e-06	6.31e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—hematologic cancer	7.76e-06	6.08e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NRAS—hematologic cancer	7.74e-06	6.07e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAPK3—hematologic cancer	7.42e-06	5.81e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTEN—hematologic cancer	7.27e-06	5.7e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—hematologic cancer	7.21e-06	5.65e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—hematologic cancer	7.2e-06	5.64e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—EP300—hematologic cancer	6.93e-06	5.43e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—hematologic cancer	6.67e-06	5.22e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—hematologic cancer	6.12e-06	4.8e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HRAS—hematologic cancer	5.67e-06	4.44e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—hematologic cancer	5.42e-06	4.25e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—hematologic cancer	5.13e-06	4.02e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—hematologic cancer	5e-06	3.92e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—hematologic cancer	4.19e-06	3.28e-05	CbGpPWpGaD
